US Army backs Recce’s synthetic antibiotic for burns Posted on February 10, 2026 by recce_com US Army backs Recce’s synthetic antibiotic for burns
Break it Down: Recce expands US Army research deals to fight deadly pathogens Posted on February 5, 2026 by recce_com Break it Down: Recce expands US Army research deals to fight deadly pathogens
Executive Edge: James Graham on Recce’s fight against superbugs Posted on February 5, 2026 by recce_com Executive Edge: James Graham on Recce’s fight against superbugs
Recce expands US government collaborations Posted on February 5, 2026 by recce_com Recce expands US government collaborations
2025 Wrapped: Recce Pharmaceuticals wraps up a healthy past 12 months Posted on December 19, 2025 by recce_com 2025 Wrapped: Recce Pharmaceuticals wraps up a healthy past 12 months
Break it Down: Recce in pole position for mega tax rebate Posted on December 17, 2025 by recce_com Break it Down: Recce in pole position for mega tax rebate
R327 shows strong efficacy in lung infection trial Posted on December 3, 2025 by recce_com R327 shows strong efficacy in lung infection trial
WHO 2025 Antibacterial Pipeline Report Posted on October 20, 2025October 20, 2025 by recce_com WHO 2025 Antibacterial Pipeline Report
Recce Pharmaceuticals Targets Diabetic Foot Infections With First-in-Class Synthetic Anti-Infective Posted on October 9, 2025 by recce_com Recce Pharmaceuticals Targets Diabetic Foot Infections With First-in-Class Synthetic Anti-Infective
Recce’s RECCE® 327 Topical Gel targets superbugs, speeds wound healing Posted on August 19, 2025 by recce_com Recce’s RECCE® 327 Topical Gel targets superbugs, speeds wound healing
